What happens after mpox treatment? Doctors describe lingering skin lesions

When you finish a course of medicine, you expect to get better. But doctors in New York City are sharing an observation that's making them look closer: some patients treated for mpox with the antiviral drug tecovirimat later developed new skin lesions. This is a report from the field, a note from clinicians about what they are seeing in their patients after treatment ended. The report simply describes that these post-treatment lesions happened. It doesn't tell us how many patients were affected, how severe the lesions were, or if they were directly caused by the treatment or the virus itself. There's no information on other side effects or how patients ultimately fared. Because this is a descriptive report and not a controlled study, it can't prove anything. It serves as an alert for other doctors to pay attention to this possibility in their own patients recovering from mpox.